{"id":"W2061761565","doi":"10.1007/s11102-013-0539-4","title":"Pasireotide monotherapy in Cushing’s disease: a single-centre experience with 5-year extension of phase III Trial","year":2013,"lang":"en","type":"article","venue":"Pituitary","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôtel-Dieu de Montréal; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Novartis Pharma; Sanofi; Canadian Society of Endocrinology and Metabolism; Eli Lilly and Company; Society for Endocrinology; Novartis","keywords":"Pasireotide; Medicine; Cushing's disease; Adverse effect; Clinical trial; Internal medicine; Tolerability; Disease; Surgery; Acromegaly","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000479172,0.0001847633,0.0003637981,0.0001111588,0.00003822143,0.00001060448,0.00007218013,0.00004228572,0.0003819345],"category_scores_gemma":[0.00003229058,0.0001276433,0.00007971068,0.0001691514,0.00007937947,0.0002229027,0.00002059106,0.00008648708,0.00002324519],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004521314,"about_ca_system_score_gemma":0.00007579214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006441029,"about_ca_topic_score_gemma":0.00006201361,"domain_scores_codex":[0.9988068,0.00003414593,0.0002988248,0.0003179492,0.0002723597,0.0002699625],"domain_scores_gemma":[0.9992601,0.00003455466,0.00008076201,0.0003466471,0.00005937023,0.000218559],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2640486,0.02677781,0.6476026,0.0001985262,0.0003411681,0.001211382,0.007878779,0.00003135321,0.008596386,0.0001634268,0.003233163,0.03991687],"study_design_scores_gemma":[0.7227764,0.006727379,0.2603709,0.0009536375,0.0002730296,0.00002511807,0.003590707,0.0008582603,0.001585026,0.001343344,0.0008344434,0.0006618028],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963762,0.000890204,0.00007278616,0.0006477368,0.0000831596,0.001343115,0.00001044861,0.00003721969,0.0005391336],"genre_scores_gemma":[0.9986888,0.00008119003,0.0004666717,0.0002838377,0.00006031509,0.00009954343,0.00005516435,0.0000227116,0.0002417593],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4587277,"threshold_uncertainty_score":0.5205144,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02207781473165354,"score_gpt":0.2754599877746958,"score_spread":0.2533821730430423,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}